• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡介导的抗miR偶联生物金纳米颗粒用于体内肿瘤靶向递送

Extracellular Vesicle-Mediated Delivery of AntimiR-Conjugated Bio-Gold Nanoparticles for In Vivo Tumor Targeting.

作者信息

Pourali Parastoo, Neuhöferová Eva, Yahyaei Behrooz, Svoboda Milan, Buchnarová Adéla, Benson Veronika

机构信息

Department of Chemistry, University of Wyoming, 1000 E. University Ave., Laramie, WY 82071, USA.

Institute of Microbiology, Czech Academy of Sciences, 142 20 Prague, Czech Republic.

出版信息

Pharmaceutics. 2025 Aug 5;17(8):1015. doi: 10.3390/pharmaceutics17081015.

DOI:10.3390/pharmaceutics17081015
PMID:40871036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389129/
Abstract

Extracellular vesicles (EVs) are involved in cell-to-cell communication and delivery of signaling molecules and represent an interesting approach in targeted therapy. This project focused on EV-mediated facilitation and cell-specific delivery of effector antimiR molecules carried by biologically produced gold nanoparticles (AuNPs). First, we loaded EVs derived from cancer cells 4T1 with AuNPs-antimiR. The AuNPs were also decorated with or without transferrin (Tf) molecules. We examined parental cell-specific delivery of the AuNPs-Tf-antimiR within monocultures as well as co-cultures in vitro. Subsequently, we used autologous EVs containing AuNPs-Tf-antimiR to target tumor cells in a xenograft tumor model in vivo. Efficacy of the antimir transfer was assessed by qPCR and apoptosis assessment. In vitro, EVs loaded with AuNPs-antimiR were internalized only by the parental cells and the AuNPs-antimiR transfer was successful and effective only in EVs that were decorated with Tf. We achieved effective delivery of the antimiR molecule into cancer cells in vivo, which was proved by specific silencing of the target oncogenic miRNA as well as induction of cancer cells apoptosis. EVs represent an interesting and potent way for targeted cargo delivery and personalized medicine. On the other hand, there are various safety and efficacy challenges that remain to be addressed.

摘要

细胞外囊泡(EVs)参与细胞间通讯和信号分子传递,是靶向治疗中一种引人关注的途径。本项目聚焦于由生物合成的金纳米颗粒(AuNPs)携带的效应抗miR分子的EV介导促进作用和细胞特异性递送。首先,我们用AuNPs - antimiR装载源自癌细胞4T1的EVs。AuNPs还用转铁蛋白(Tf)分子进行了修饰或未修饰。我们在体外单一培养物以及共培养物中研究了AuNPs - Tf - antimiR的亲代细胞特异性递送。随后,我们在体内异种移植肿瘤模型中使用含有AuNPs - Tf - antimiR的自体EVs靶向肿瘤细胞。通过qPCR和凋亡评估来评估抗miR转移的效果。在体外,装载有AuNPs - antimiR的EVs仅被亲代细胞内化,并且AuNPs - antimiR转移仅在用Tf修饰的EVs中成功且有效。我们在体内实现了抗miR分子向癌细胞的有效递送,这通过靶致癌miRNA的特异性沉默以及癌细胞凋亡的诱导得到证明。EVs是靶向货物递送和个性化医学中一种有趣且有效的方式。另一方面,仍有各种安全性和有效性挑战有待解决。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/a7982ff04330/pharmaceutics-17-01015-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/8166a929a78c/pharmaceutics-17-01015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/7088527ef03d/pharmaceutics-17-01015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/e707c044fd75/pharmaceutics-17-01015-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/2dd4fb8a805c/pharmaceutics-17-01015-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/f82afc3964ac/pharmaceutics-17-01015-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/87f7bbb839ec/pharmaceutics-17-01015-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/d6fc683961d0/pharmaceutics-17-01015-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/0c4cd5e3ecf8/pharmaceutics-17-01015-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/431663b0ab1e/pharmaceutics-17-01015-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/d4039c08377c/pharmaceutics-17-01015-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/05d98c2ee75a/pharmaceutics-17-01015-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/1dff5c80bbb7/pharmaceutics-17-01015-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/971d30fb0d85/pharmaceutics-17-01015-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/a7982ff04330/pharmaceutics-17-01015-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/8166a929a78c/pharmaceutics-17-01015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/7088527ef03d/pharmaceutics-17-01015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/e707c044fd75/pharmaceutics-17-01015-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/2dd4fb8a805c/pharmaceutics-17-01015-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/f82afc3964ac/pharmaceutics-17-01015-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/87f7bbb839ec/pharmaceutics-17-01015-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/d6fc683961d0/pharmaceutics-17-01015-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/0c4cd5e3ecf8/pharmaceutics-17-01015-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/431663b0ab1e/pharmaceutics-17-01015-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/d4039c08377c/pharmaceutics-17-01015-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/05d98c2ee75a/pharmaceutics-17-01015-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/1dff5c80bbb7/pharmaceutics-17-01015-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/971d30fb0d85/pharmaceutics-17-01015-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e4/12389129/a7982ff04330/pharmaceutics-17-01015-g014.jpg

相似文献

1
Extracellular Vesicle-Mediated Delivery of AntimiR-Conjugated Bio-Gold Nanoparticles for In Vivo Tumor Targeting.细胞外囊泡介导的抗miR偶联生物金纳米颗粒用于体内肿瘤靶向递送
Pharmaceutics. 2025 Aug 5;17(8):1015. doi: 10.3390/pharmaceutics17081015.
2
Isolation and characterization of bone mesenchymal cell small extracellular vesicles using a novel mouse model.利用新型小鼠模型分离和鉴定骨髓间充质细胞的小细胞外囊泡。
J Bone Miner Res. 2024 Oct 29;39(11):1633-1643. doi: 10.1093/jbmr/zjae135.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Autologous extracellular vesicles derived from conjunctival squamous cell carcinoma deliver therapeutic microRNAs to induce apoptosis in originating cancer.源自结膜鳞状细胞癌的自体细胞外囊泡递送治疗性微小RNA以诱导原发癌发生凋亡。
J Mater Chem B. 2025 Aug 27;13(34):10460-10474. doi: 10.1039/d5tb00587f.
5
Ribosomal protein L36-mediated selective loading of microRNA-4432 into extracellular vesicles contributes to perivascular cell dysfunction in venous malformations.核糖体蛋白L36介导的微小RNA-4432选择性装载到细胞外囊泡中,导致静脉畸形中血管周围细胞功能障碍。
Br J Dermatol. 2025 Mar 18;192(4):717-727. doi: 10.1093/bjd/ljae492.
6
The RNA binding protein IGF2BP2/IMP2 alters the cargo of cancer cell-derived extracellular vesicles supporting tumor-associated macrophages.RNA 结合蛋白 IGF2BP2/IMP2 改变了肿瘤相关巨噬细胞支持的癌细胞衍生细胞外囊泡的货物。
Cell Commun Signal. 2024 Jun 27;22(1):344. doi: 10.1186/s12964-024-01701-y.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
10
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.

本文引用的文献

1
Bioproduced Nanoparticles Deliver Multiple Cargoes via Targeted Tumor Therapy In Vivo.生物合成纳米颗粒通过靶向肿瘤疗法在体内递送多种药物。
ACS Omega. 2024 Jul 23;9(31):33789-33804. doi: 10.1021/acsomega.4c03277. eCollection 2024 Aug 6.
2
Accumulation and toxicity of biologically produced gold nanoparticles in different types of specialized mammalian cells.生物合成的金纳米颗粒在不同类型的哺乳动物特化细胞中的积累与毒性
Biotechnol Appl Biochem. 2024 Aug;71(4):766-778. doi: 10.1002/bab.2575. Epub 2024 Mar 13.
3
Tumor-derived extracellular vesicle drug delivery system for chemo-photothermal-immune combination cancer treatment.
用于化疗-光热-免疫联合癌症治疗的肿瘤源性细胞外囊泡给药系统
iScience. 2024 Jan 8;27(2):108833. doi: 10.1016/j.isci.2024.108833. eCollection 2024 Feb 16.
4
Conjugation of microbial-derived gold nanoparticles to different types of nucleic acids: evaluation of transfection efficiency.将微生物衍生的金纳米粒子与不同类型的核酸连接:转染效率的评估。
Sci Rep. 2023 Sep 6;13(1):14669. doi: 10.1038/s41598-023-41567-7.
5
Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid.靶向和释放核酸的脂质纳米粒子的优化。
Adv Mater. 2024 Jan;36(4):e2305300. doi: 10.1002/adma.202305300. Epub 2023 Nov 30.
6
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.用于体内 RNA 递送的脂质纳米颗粒 (LNPs) 及其未来应用的突破性技术。
Adv Drug Deliv Rev. 2023 Sep;200:114990. doi: 10.1016/j.addr.2023.114990. Epub 2023 Jul 7.
7
Fate of the capping agent of biologically produced gold nanoparticles and adsorption of enzymes onto their surface.生物合成金纳米粒子的盖帽剂的命运和酶在其表面的吸附。
Sci Rep. 2023 Mar 25;13(1):4916. doi: 10.1038/s41598-023-31792-5.
8
Extracellular vesicles and nanoparticles: emerging complexities.细胞外囊泡和纳米颗粒:不断涌现的复杂性。
Trends Cell Biol. 2023 Aug;33(8):667-681. doi: 10.1016/j.tcb.2023.01.002. Epub 2023 Feb 1.
9
Investigation of Protein Corona Formed around Biologically Produced Gold Nanoparticles.生物合成金纳米颗粒周围形成的蛋白质冠层研究。
Materials (Basel). 2022 Jun 30;15(13):4615. doi: 10.3390/ma15134615.
10
Mammalian Cells Exocytose Alkylated Gold Nanoparticles Extracellular Vesicles.哺乳动物细胞通过胞吐作用释放烷基化金纳米颗粒细胞外囊泡。
ACS Nano. 2022 Feb 22;16(2):2032-2045. doi: 10.1021/acsnano.1c07418. Epub 2022 Feb 9.